Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Adv Therapy

Search In Journal Title:

Abbravation: Advances in Therapy

Search In Journal Abbravation:

Publisher

Springer Healthcare Communications

Search In Publisher:

DOI

10.1002/lipi.19910930908

Search In DOI:

ISSN

1865-8652

Search In ISSN:
Search In Title Of Papers:

Corneal staining reductions observed after treatme

Authors: Mike T Christensen
Publish Date: 2008/10/29
Volume: 25, Issue: 11, Pages: 1191-1199
PDF Link

Abstract

Because of the added emphasis on ocular surface damage included in the Dry Eye Workshop’s revised definition of dry eye an evaluation of corneal staining reductions was conducted for propylene glycol/polyethylene glycol 400based artificial tear drops Systane® Lubricant Eye Drops Alcon Laboratories Fort Worth TX USAAn analysis was conducted on the percent change from baseline in mean corneal staining scores as reported in two previously published randomized doublemasked 6week clinical studies of Systane A descriptive comparison was also made between the outcome of the composite analysis and data obtained for Optive™ Lubricant Eye Drops Allergan Inc Irvine CA USA Finally results were reviewed for an openlabel study that investigated corneal staining over a 5week period after patients discontinued Systane therapyThe composite analysis included 107 Systanetreated patients The results showed that Systane consistently reduced corneal staining at each visit the percent change from baseline to day 42 exit was 471 P00001 After discontinuing Systane immediate and significant increases in corneal staining were reported by 20 patients with an overall increase from baseline to day 35 exit of 1950 P00001Evaluations of sum corneal ocular staining scores provide clinically meaningful evidence of dry eye severity and are an important indicator of dry eye disease progression The results of the composite analysis of two peerreviewed studies indicate that Systane significantly reduced corneal staining P00001 indicating a reduction in the severity of dry eye Finally discontinuation of Systane results in a rapid increase in corneal staining that further confirms Systane’s ability to maintain ocular surface health


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Azacytidine for the treatment of myelodysplastic syndromes in the elderly
  2. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  3. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  4. When People with Opioid-Induced Constipation Speak: A Patient Survey
  5. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
  6. Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
  7. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
  8. A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  9. Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  10. Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy
  11. Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis
  12. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment
  13. Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?
  14. An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
  15. Slovak Trial on Cardiovascular Risk Reduction Following National Guidelines with CaDUET® (The STRONG DUET Study)
  16. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
  17. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
  18. Advances in Clinical Cardiology
  19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
  20. Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β 1 -Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
  21. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals
  22. Glial fibrillary acidic protein (GFAP) and CD34 expression in the human optic nerve and brain in methanol toxicity
  23. Urapidil, a dual-acting antihypertensive agent: Current usage considerations

Search Result: